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Abstract
Background: Fetal bovine serum (FBS) contains a wide range of growth factors, hormones, vitamins, amino acids,
fatty acids and trace elements required for cell growth. It was shown that animal sera contain also extracellular
vesicles (EVs) with important biological properties; thus we wondered whether EVs present in FBS would influence
muscle cell phenotype.
EVs were removed from sera by ultracentrifugation (18 h). C2C12, L6 and human primary myoblasts, were grown either
in classical media (CM) or in EVs-depleted media. Differentiation was induced by replacing the culture medium either
with CM or EV-depleted media. qRT-PCR of relevant genes and miRNA involved in proliferation, differentiation, energy
metabolism and EVs formation and secretion were performed.
Results: Growth of myoblasts in EV-free media during proliferation produces the most unfavorable situation for proper
myotube formation, when considering C212 and human myoblasts. Removing EVs from serum committed myoblasts
to differentiate precociously (induction of myogenin and decreased expression of myomiR involved in myogenesis).
C2C12 and human myoblasts, grown constantly in EV-depleted media during proliferation and differentiation, formed
less myotubes than in CM. They had a reduced level of myogenin and a strong increase in myostatin expression,
a negative regulator of muscle cell differentiation that affects myotube size. This situation was not reversed
when confluent myoblasts were switched to CM for differentiation. Like C2C12 and human cells, L6 formed
less myotubes in EVs-depleted media. However, as they do not express myostatin, L6 myotubes were larger
and expressed higher level of CKTM2 compared to myotubes grown in CM suggesting that they had reached
a higher level of differentiation.
Conclusions: Researchers studying the role of muscle EVs in culture conditions should consider that depleting EVs
from serum alters the phenotype of muscle cells. Interestingly, the cross-talk between myoblasts and myotubes during
myogenesis (Forterre 2014, PLoS One. 2014 Jan 2;9(1):e84153) can be recapitulate by using FBS-EVs as well. This implies
that EVs can transfer specific signals to cells from unrelated species and that part of serum EV composition is
evolutionarily conserved (e.g.; myomiR are detected in FBS-EVs). EVs in body fluids could have an unsuspected
function during embryogenesis and in regulation of cellular processes such as hypertrophy and hyperplasia.
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Background
Fetal bovine serum (FBS) obtained from the clotted
blood of the bovine fetus, is a common supplement to in
vitro culture media. It contains a wide range of growth
factors, hormones, vitamins, amino acids, fatty acids and
trace elements required for cell growth and, for this rea-
son, was introduced early in cell biology research [1, 2].
It is well-known that animal sera exhibit very high levels
of batch to batch variations which can affect cellular
proliferation, differentiation, and function. For instance,
considerable lots of FBS contain significant levels of
lipopolysaccharides which can affect the production of
Tumor Necrosis Factor by macrophages [3]. In the case
of the C2C12 cell line, which is typically used as a
‘model systems’ for understanding muscle growth and
development, it has been demonstrated that differences
in hormonal content depending on serum origin (e.g.;
USA vs EU) caused a shift in calcium handling, resulting
in a dramatic change in muscle cell spontaneous
contractility [4]. Recently, it was shown that animal sera
contain extracellular vesicles (EVs) (e.g.; exosomes,
microparticles and apoptotic bodies) which also have
important biological properties ranging from intercellu-
lar communication and angiogenesis to cell survival.
These vesicles can be distinguished by their size and
lipid composition: microvesicles (50–300 nanometers)
originate from blebbing of the plasma membrane,
exosomes (30–150 nanometers) originate from fusion
of late endosomes (multivesicular bodies) with the
plasma membrane, and apoptotic bodies (100–5000
nanometers) originate from apoptotic cells. EVs,
containing certain combinations of lipids, adhesion
and intercellular signaling molecules as well as RNAs,
participate in intercellular communication processes
[5, 6]. Depending on their origin, EVs can modulate
immune-regulatory processes, set up tumor escape
mechanisms and mediate regenerative or degenerative
processes, amongst others. Numerous studies have re-
ported changes in EV composition induced by modifi-
cations of the culture conditions, which can mimic
different extracellular environments or different
physiological or differentiation states of the secreting
cells. Thus EVs in biological fluids such as serum or
plasma are now considered as biomarkers for diagno-
sis purposes [7]. Recently, 3 studies have suggested
that EVs from bovine serum could substantially influ-
ence cultured cell behavior and phenotype [8–10] as
vesicle-depleted FBS have reduced capacity to support cell
growth. It was also described that FBS vesicles mediated
anchorage-independent growth of breast carcinoma cells
[11] and thus were necessary for cellular adhesion. As
muscle cells are very dependent on FBS origin for prolifer-
ation and differentiation [4], we wondered whether EVs
present in FBS also affected myoblasts proliferation and
differentiation and thus if FBS-EVs could influence cul-
tured muscle cell phenotype.
Therefore, in this study we have determined the spe-
cific effect of FBS-EVs on myoblast proliferation and
differentiation using mouse and rat muscle cell lines or
human primary myoblasts. Our results show that re-
moval of EVS from FBS affected proliferation of myo-
blasts and committed cells to differentiate precociously.
In addition, the expression of myomiRs important for
the myogenic process and induced during myoblast
proliferation (i.e; miR-1, miR-206, miR-133a) are sig-
nificantly decreased in C2C12. Myoblasts constantly
grown in EV-depleted media during proliferation and
differentiation formed less myotubes than myoblasts
grown in normal serum. However, this study shows a
divergence in muscle cell differentiation, depending on
the origins of the myoblasts, towards EV-depleted treat-
ments. Thus, researchers studying the role of muscle
EVs in culture conditions should consider that deplet-
ing EVs from FBS significantly alters the phenotype of
muscle cells by affecting gene and miRNA expressions
during proliferation.
Results
Fetal serums may contain more than a thousand compo-
nents, many related to factors that have been shown to
have a large effect on the muscle cell development. The
identities and concentrations of these substances in
serum are not well characterized. Therefore the use of
serum introduces a large number of confounding vari-
ables to any experiment. In this study we tested the role
of EVs on myoblast proliferation and differentiation
using the mouse cell line C2C12, the rat cell line L6 and
human primary myoblasts isolated from muscle biopsies.
EVs were removed from sera by ultracentrifugation for
at least 18 h based on previous observations suggesting
that shorter centrifugation time periods are not suffi-
cient to get EV-free sera [9]. Proteins of the EV pellets
were quantified using the Bradford Protein Assay (BPA).
We estimated that 10 % FBS DMEM contained 10 μg of
EV-derived proteins per ml of medium. The size of the
particles and their concentrations were also analysed
with Nanoparticle Tracking Analysis (NTA). NTA calcu-
lation of EV-derived proteins produced a concentration
which was 4 times less than obtained when quantified
with BPA indicating that EVs might be contaminated
with other proteins, likely serum albumin and immuno-
globulin [12]. The vesicle size distribution determined
by NTA displayed a bell-shaped curve with a peak at
81 nm (+39 nm) in agreement with the reported size of
EVs (Fig. 1a). As sera are usually filtered at 0.1 um by
the supplier, it is likely that the EV pellet is strongly
enriched in exosomal vesicles, which are smaller than
microparticles and apoptotic bodies [13]. In agreement,
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classical exosomal markers were detected by WB and
TEM on FBS-EVs (Fig. 1b-c, respectively).
Removal EVs from culture medium affects myoblast
proliferation
Myoblasts, plated at the same density, were grown either
in Control Media (CM) or in Serum EVs-Depleted
Media (SEDM) (See Additional file 1: Table S1 for
growth conditions). After 3 days, light microscopy ana-
lysis showed that SEDM affected myoblast proliferation
(Fig. 2a). In agreement, the number of nuclei was higher
for the cells grown in CM than in SEDM (Fig. 2b).
C2C12 and L6 grown in SEDM had reduced Cyclin
D1 and Sirt1 mRNA levels, two important genes in-
volved in cell proliferation [14, 15], compared to CM-
treated cells (Fig. 3a-b). Cyclin D1 reduction level was
also observed for human myoblasts grown in SEDM
(Fig. 3c). It has to be noticed that human myoblasts are
grown with only 2 % FBS conversely to L6 and C2C12
which are cultured with 10 % FBS, suggesting that even
at low concentrations, FBS-EVs have an impact on cell
proliferation. We also measured the expression of genes
involved in multivesicular bodie formation (i.e.; VPS37B
and VPS4A). Indeed, besides their newly identified roles
in cell-cell communications, it should not be forgotten
that EVs release is the major route for protein and
lipid recycling during plasma membrane remodeling.
Thus, EVs secretion is highly stimulated during cell
proliferation. We found that VPS37B and VPS4A
were decreased at the transcriptional level in C2C12
myoblasts grown in SEDM and VPS4A was reduced
in L6 myoblasts, suggesting that reducing proliferation
also reduced EV formation and vesicular trafficking.
Although not significant, the same tendency was observed
for human myoblasts grown without serum EVs (Fig. 3c)
In the case of muscle cells, cell cycle exit and differ-
entiation are coupled during myogenesis [16]. Thus, to
determine whether reduced myoblast proliferation in
SEDM was correlated with the entrance in the differen-
tiation step, we measured the expression of myogenin,
considered as one of the earliest molecular markers for
myotube formation in vitro, and MyoD, which cooper-
ate with CyclinD1 during proliferation [17]. As shown
on Fig. 3a-b-c, myoblasts grown in SEDM exhibited
higher level of myogenin mRNA than control cells,
strongly suggesting that these growth conditions in-
duced myoblast growth arrest and committed cells to
differentiate precociously. In agreement, MyoD mRNA
level was reduced in C2C12, concomitantly to Cyclin
D1 (Fig. 3a). In addition, the expression of myomiRs
A B
C
Fig. 1 Fetal bovine serum (FBS) contain exosome-like vesicles. FBS-derived vesicles were pellet at 100,000 g for 18 h, resuspended in PBS
and re-pelleted at 100,000 g for 70 min. a FBS-EV size distributions measured with Nanosight. b Immuno-blotting for enriched exosomal proteins in
FBS (1); C2C12 released exosomes were used as positive controls (2). TSG101 = Tumor susceptibility gene 101, CD81 = Cluster of Differentiation 81
(tetraspanin). c TEM images of purified FBS-EVs. Nanovesicles are labeled with anti-CD81 gold particles to confirm their exosomal origin
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important in the myogenic process, which are induced
during myoblast proliferation (i.e; miR-1, miR-206,
miR-133a [18]), were significantly decreased in C2C12
grown in SEDM, confirming exit from the proliferation
step and entrance in the differentiation process (Fig. 4).
Removing EVs from sera delays myoblasts differentiation
Although myoblasts grown in serum EVs-depleted media
had reduced rate of proliferation, they were able to pro-
liferate until confluence. After confluence (4 days in pro-
liferation medium), myoblast differentiation was induced
by replacing proliferation media with either control
media containing serum EVs (CM) or with differenti-
ation media without serum EVs (SEDM) (see Fig. 5a).
After 8 days post-differentiation, cells were harvested for
RNA extraction and gene expression analysis. As
shown on Fig. 5b-c-d-e, cells constantly grown in EV-
depleted media during proliferation and differentiation
(SEDM_SEDM), formed less myotubes than cells
grown in control media (CM_CM). In agreement
C2C12 and human cells had a reduced level of
myogenin mRNA (MyoG) and a strong increase in
myostatin expression (a negative regulator of skeletal
muscle size, which inhibits muscle cell differentiation
[19]) (Fig. 6). C2C12 and human cells constantly











































Fig. 2 FBS-derived vesicles are involved in myoblast proliferation.
a light-microscopy (x4) of representative wells from C2C12, L6 or
human primary myoblasts grown in 6-well plates either in normal
proliferative medium or EV-depleted proliferative medium. b Mean












































































































































































Fig. 3 Removing FBS-derived vesicles from bovine serum affects gene
expression. Quantitative RT-PCR of relevant genes for proliferation (Cyclin
D1, Sirt1), differentiation (MyoD, MyoG), metabolism (Glut4) and vesicle
trafficking and EV release (TSG101, VPS37B, VPS4). Data are expressed as
fold compared to CM, normalized by house keeping gene (HKG). In
white, cells grown in control media containing FBS-EVs (CM), in black,
cells grown in CM depleted of FBS-EVs (SEDM). a C2C12 myoblasts; b L6
rat myoblasts; c human primary myoblasts
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levels of PGC1-α (involved in involved in energy me-
tabolism) and of CKMT2 mRNA level (which has a
central role in energy transduction in muscle cells)
suggesting that these myotubes had altered substrate
utilization compared to those cultivated in normal
conditions. Of note, rat L6 myotubes do not express
myostatin and conversely to the other cell types, had
increased level of CKMT2 when grown in SEDM dur-
ing proliferation and differentiation. For the 3 cell
types, removal of serum EVs did not affect Atrogin-1
expression level, a muscle specific protein regulating
muscle atrophy.
Myoblasts grown in SEDM during proliferation
were switched to classical CM for differentiation
(SEDM_SEDM vs SEDM_CM on Fig. 6). After 8 days
in differentiation media, C2C12 and L6 myotubes grown
in SEDM_CM had higher level of MyoG, and C2C12 and
human myotubes had decreased level of myostatin when
compared to cells constantly grown without EVs, suggest-
ing that they had reached a higher level of differentiation.
However, at the same time, C2C12 and human myotubes
had reduced levels of Atrogin-1 suggesting that for these 2
cell types, SEDM_CM treatment increased myotube size
without affecting the number myotubes (i.e.; the same
quantity of RNA was extracted from myotubes grown in
SEDM_CM vs SEDM_SEDM although Fig. 5b and d
showed a reduced number of myotubes in SEDM_CM
condition compared to CM_CM condition). Human myo-
tubes expressed higher level of Il-6 when grown in
SEDM_CM than in CM_CM suggesting a modification of
their secretome.
L6 myotubes, which do not express myostatin, displayed
a specific behavior. When grown in SEDM_SEDM or
SEDM_CM compared to CM_CM or CM_SEDM condi-
tions, they formed less myotubes (Fig. 5e), but these myo-
tubes were larger (Fig. 5c) with an increase level of
CKMT2 mRNA (Fig. 6). This result suggests that growing
myoblast L6 in SEDM during proliferation is favorable for
myotube size for this cell type, conversely to C2C12 and
human myotubes.
We also tested the reverse experiment i.e.; myoblasts
grown in a CM for proliferation were switched in EV-free
medium for differentiation (CM_SEDM vs CM_CM on
Fig. 6). After 8 days in differentiation medium, C2C12 and
L6 myotubes grown in CM_SEDM had reduced levels of
MyoG, PGC1-α and Atrogin-1 suggesting that these cells
were less differentiated than when grown in normal
medium. Compared to cells grown in normal conditions,
CM_SEDM treated C2C12 and human myotubes formed
roughly the same number of myotubes as indicated by the
quantity of total RNA recovered in both treatments
(Fig. 5d). However, this growth condition affected the
number of L6 myotubes (Fig. 5c-d).
Taken altogether, we concluded that growth of
myoblasts in EV-free media during proliferation pro-
duces the most unfavorable situation for proper myo-
tube formation when considering C212 and human
myoblasts. In EV-free media, myostatin is strongly
increased and dramatically affects myotubes forma-
tion and likely the expression of myomiR involved in
myogenesis [20], at least for C2C12. This situation is
not reversed when the cells are switched from SEDM
to CM for the step of differentiation. As a conse-
quence, proliferation in SEDM affects the number of
C2C12 and human myotubes. Surprisingly, growth in
EV-free media during proliferation and then switch-
ing to CM for differentiation is favorable for rat L6
myotube size.
Bovine EVs expressed miRNAs involved in muscle
myogenesis
Myoblasts were grown either in SEDM or SEDM supple-
mented with FBS EV-derived proteins (10 μg per ml of
medium for C2C12 and L6, or 2 μg for human myo-
blasts according EVs concentrations in each growth
medium). The addition of FBS-EVs induced an increase
in Sirt1 mRNA level in C2C12 myoblasts and a decrease
in the expression of myogenin both in L6 and C2C12
myoblasts (Fig. 7). Conversely, FBS-EVs did not affect
Cyclin D1 and MyoD1 expressions in these 2 cell types,
suggesting FBS-EVs repress the induction of differenti-
ation markers during proliferation. On the contrary, the
addition of FBS-EVs induced an increase of CyclinD1
and MyoD1 in human primary myoblasts without affect-
ing myogenin, suggesting that in this model, FBS-EVs
participate in cell cycle regulation (Fig. 7).
Taken together, these data strongly suggested that
FBS-EVs participated in the process of muscle cell myo-
genesis, and that their roles are additive to other import-
ant components of bovine serum.
As it is known that EVs contain miRNAs, we won-
dered whether FBS would contain myomiR involved
in muscle cell differentiation. As shown on Fig. 8,




























Fig. 4 Removing FBS-derived vesicles from bovine serum affects
myomiR expression in C2C12. Quantification of miR-1, miR-133a
and miR-206 in C2C12, grown either in CM (white) or in EVs-depleted
proliferation media (black). Data are expressed as Ct values
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proliferation [21] were detected by PCR in FBS-EVs. The
presence of myomiR in EVs of bovine serum suggested that
they might be transferred in recipient myoblasts during cell
culture. However, as myomiRs display high evolutionary
conservation in animal kingdom it was not possible to
verify this hypothesis as murine, rat, human and bovine
myomiR sequences are identical [22].
Discussion
Until now, EVs have been widely studied for their im-
portant roles in cancer development and immune re-
sponse. This is supported by a large number of
articles within the literature describing their actions
on cell proliferation and differentiation in various tis-
sues and cell types. EVs carry numerous protein, lipid
Fig. 5 Removing EVs from culture medium sera affect myoblast differentiation. a Workflow showing myoblast growth conditions. CM = control
media containing FBS-EVs, SEDM =media depleted of FBS-EVs. b-c-d Light-microscopy (x4) of representative wells showing myotubes after 8 days
of differentiation; B = C2C12, C = L6 and D = human myotubes. e Mean quantities of total RNA/well (NanoDrop quantification) from the 3 types of
myotubes after 8 days of differentiation
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and nucleic acid components that can collectively
affect multiple signaling pathways inside recipient
cells. Because EVs are released by all tissues, mam-
mals have significant quantities of EVs in circulating
blood [23]. Locally, we have found that SkM-released
EVs participate in muscle homeostasis [24] and we
have demonstrated that myotube-released EVs are in-
volved in the process of myogenesis [25], regulating
myoblast proliferation. In order to isolate EVs from





































































































































































Fig. 6 Removing FBS-derived vesicles from bovine serum affects gene expression in myotubes. Quantitative RT-PCR of relevant genes for
differentiation (MyoG, CKMT2), myotube size (myostatin, atrogin), metabolism (PGC1-α) or encoding secreted proteins (Il-6). Data are expressed
as fold compared to CM_CM, normalized by house keeping gene (HKG). * = p < 0.01 all conditions vs CM_CM, $ = p < 0.01 SEDM_SEDM vs
SEDM_CM. £ = p < 0.01 CM_SEDM vs SEDM_CM
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remove EVs from fetal bovine serum (FBS) to ensure
that they are neither erroneously characterized nor
competing with the experimental EVs [26]. Doing this,
we have observed that C2C12 muscle cells constantly
grown in EV-depleted FBS were unable to differen-
tiate and stopped proliferating after 2-3 passages
(data not shown). Thus, we suspected that EV-depleted
FBS were important for myogenesis. In order to validate
this hypothesis we have grown two myoblastic cell lines,
mouse C2C12 and rat L6 and one human primary culture
of myoblasts, either in normal growth conditions or in
serum depleted of its EVs. Then we have quantified the
expression of specific genes known for their important
role in muscle cell proliferation (Cyclin D1, Sirt1), differ-
entiation (Myogenin, MyoD), energy metabolism (Glut4,
PGC1-α, CKMT2) and EVs secretion (TSG101, VPS37B,
VPS4). The results of the present study confirm our hy-
pothesis and demonstrate that FBS-EVs participate in the
process of myoblast proliferation. Myoblasts grown in EV-
depleted medium had affected proliferation and expressed
early markers of differentiation. As a consequence, less
myotubes were formed, an effect that could be partly
reversed by treating cells with FBS-EVs alone. Surpr-
ingly, rat cell line L6 was positively affected and
formed larger myotubes when grown in EV-depleted
medium and then switch in differentiation medium
containing EVs, compared to normal growth condi-
tion. In fact, EV-depleted proliferation medium
induced the expression of myostatin in C2C12 and
human myotubes, a negative regulator of skeletal
Fig. 7 Effect of FBS-EVs on myoblasts gene expression quantified by qRT-PCR. Data are expressed as fold compared to EV-depleted condition,
normalized by house keeping gene (HKG). In black, cells grown in serum depleted of its EVs (SEDM), in grey, cells grown in SEDM supplemented
with FBS EVs. a C2C12 myoblasts; b L6 rat myoblasts; c human primary myoblasts
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muscle cell size. As L6 cells do not expressed myosta-
tin, induction of precoce differentiation markers dur-
ing proliferation by EV-depleted medium results in
large hypertrophic myotubes. Thus study shows a
divergence in muscle cells responses to FBS-EVs
depending on their origins.
While preparing this manuscript, 3 other similar stud-
ies were published using other cell types, which con-
firmed that EVs in FBS support cell growth [8–10]. This
result was reproduced whatever the commercial source
of FBS used and with different serum batches [8].
The evidence that EVs can enter into cells and de-
liver their cargo is overwhelming. Most experimental
evidence suggests that EVs are taken up into endoso-
mal compartments via endocytosis [27] and it has
clearly been demonstrated that internalized FBS-EVs
interact with lysosomes in the recipient cells [8, 28].
As lysosomes are at the crossroads of several cellular
processes such as secretion, plasma membrane repair,
signaling and energy metabolism [29], it is likely that
internalized EVs participate in various cellular path-
ways. However, the FBS-EV components that promote
cell growth remain to be identified as EVs contain a
variety of cargoes that include cell surface receptors,
cytosolic and nuclear proteins, metabolic enzymes,
RNA transcripts, miRNAs and even DNA, that col-
lectively may participate in EV functions. EVs also
contain cellular growth factors like TGFbeta [30–32],
proteins of the Wnt [33] and Sonic Hedgehog [34]
pathways and cytokine [35] required for proliferation.
All these components could participate in FBS-EVs
biological actions.
Numerous studies have also demonstrated the transfer
of miRNAs from EVs to recipient cells. Interestingly, 2
miRNAs involved in myogenesis are detected in FBS-
EVs (i.e.; miR-133a and miR-1). Recently, it was demon-
strated that miRNAs exported in EVs can be transferred
between unrelated species (e.g.; nematode parasite-
derived miRNAs are transferred and regulate murine
host genes [36]). It is thus tempting to speculate that
bovine EV-miRNAs might participate in the regulation
of genes involved in myogenesis in C2C12 recipient
cells. Indeed, we have found 675 bovine miRNAs which
are predicted to bind the murine myogenin 3’UTR re-
gion (Additional file 2: Table S2), including miR-1 and
miR-133a. It is tempting to speculate that bovine EV-
miRNAs might collectively participate in reducing the
level of expression of this gene during myoblast
proliferation.
It can be also envisaged that EV internalization might
not always be necessary to elicit a phenotypic response
by skeletal muscle cells. Indeed, because of their ability
to bind to plates coated with fibronectin [37], EVs would
aid in myoblast attachment as they express integrin re-
ceptors known to mediate cell adhesion [25]. It would
therefore be interesting to further study whether FBS-
EVs can be used on biomaterial surfaces as a possible
strategy to improve performance of cell culture and
tissue engineering.
The other important message is that removing FBS-
EVs from culture medium affects gene and miRNA
expressions and likely the proteome of the cells.
Numerous studies, including ours, have found that
the contents of EVs often contain distinguishing sig-
natures that allow them to be traced back to their
cell of origin. Based on this observation, circulating
EVs are now considered as potential disease bio-
markers. Therefore a lot of proteomic and genomic
analyses have been performed on EVs collected from
conditioned medium depleted of FBS-EVs in order to
have specific cell-type and tissue EV signatures
(http://www.microvesicles.org/). Given the results of
the present study, it is conceivable and likely that
part of the EV signatures already published might be
affected by removal of FBS-EVs during EV collection.
Interestingly, our data showed that we can recapitu-
late the cross-talk between myoblast and myotubes
previously demonstrated [25, 38] by using EVs from
serum as well. Indeed FBS-EVs, as myotube-EVs, can
affect proliferation of myoblasts and can induce their
entrance in the differentiation process. This result
implies that bovine EVs can transfer specific signals
to cells from unrelated species (i.e.; to mice, rat and
human) and thus that part of EV composition is
evolutionarily conserved between these mammalian
species. Generally speaking, these results suggest that
EVs in body fluids could have an unsuspected func-
tion during embryogenesis and in the regulation of
cellular adaptations that lead to hypertrophy, hyper-
plasia and metaplasia.
Recently, a number of laboratories have started to
develop new strategies to use EVs as vehicles for DNA



















Fig. 8 FBS-EVs contain miRNA involved in myogenesis (myomiRs).
Data are expressed as Ct values
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Given the strong impact of EVs on cell proliferation
described previously and confirmed in this study, as well
as the lack of knowledge on the EV cargoes involved in
this biological action, we consider that it is important to
keep in mind that EVs are capable of inducing changes
in recipient cells.
Conclusions
Researchers studying the role of muscle EVs in culture
conditions should consider that depleting EVs from FBS
significantly alters the phenotype of muscle cells by
affecting gene and miRNA expressions during prolifera-
tion. Further studies are now necessary to elucidate the
molecular mechanisms by which EVs in serum enhance
cell proliferation in order to develop serum-free media
that support rapid cell growth.
Methods
Removal and isolation of EVs from FBS and HS
We used FBS from PAA laboratories (PAA clone, # A-
15-102, serum with low endotoxin content supple-
mented with BSA). According to the supplier, blood is
removed from the foetus by aseptic cardiac puncture
and is then centrifuged to separate blood cells from the
serum. The serum is then passed through a cascade of
triple 0.1 um filters.
Preparation of EV-depeted DMEM (D-DMEM)
DMEM, supplemented with all nutrients (4.5 g/l glucose,
1000 IU/ml penicillin, 1000 IU/ml streptomycin,
2 mM L-Glutamine) and 20 % (v/v) heat-inactivated
FBS, was ultracentifuged at 100,000 g overnight at 4 °
C (Beckman-Coulter, Optimatm L-80-XP ultracentri-
fuge, type 50-2Ti rotor) [9, 26]. The supernatant was
filtered through a 0.22 um filter and diluted with
serum-free DMEM to reach the final serum concen-
tration (Additional file 1: Table S1). The pellets from a
single sample were pooled, resuspended in 25 ml of PBS
and again centrifuged at 100,000 g for 70 min. The EV
pellet was finally resuspended in 100ul PBS. EV protein
content was quantified using the Bradford protein assay.
A NanoSight (Malvern Instruments, Orsay, France) was
employed to measure the size of particles [40]. The num-
ber of particles and their movement were recorded for
1x60s and analyzed using the NS500 software.
MicroRNA isolation from culture medium or EVs
Total RNA was extracted from either 100 μl of culture
medium (CM or SEDM) or 100 μg of FBS-EVs by using
TriPure Isolation Reagent (Roche Applied Science,
France). RNA was quantified with a NanoDrop 2000c
UV-Vis Spectrophotometer (Thermo Fisher Scientific).
Origin of myoblasts and culture conditions
Experiments were performed either with immortalized
murine C2C12 myoblasts (ATCC® CRL1772™) or rat L6
myoblasts (ATCC® CRL-1458™), or human primary myo-
blasts. Growth culture conditions are summarized in
Additional file 1: Table S1. All myoblasts were grown at
37 °C under 5 % CO2 atmosphere. Differentiation was
induced when myoblasts reached confluence and were
grown in differentiation media for 8 days.
For the culture of human muscle cells, muscle biopsies
(about 200 mg wet weight) were taken under local anaes-
thesia from the vastus lateralis muscle from a lean volon-
teer who gave his written consent after being informed of
the nature, purpose and possible risks of the study. The
protocol was approved by the ethics committee of the Hos-
pices Civils de Lyon (#12/111). Differentiated myotubes
were prepared according to the procedure previously
described [41]. After selection of the myoblasts using a
monoclonal antibody (5.1H11; Developmental Studies
Hybridoma Bank, Iowa City, IA, USA) combined with
magnetic beads, myoblasts were cultured in a Primaria flask
(Falcon; Becton Dickinson, Bedford, MA, USA) in a growth
medium containing Ham’s F10 supplemented with 2 %
Ultroser G (BioSepra, Cergy-Saint-Christophe, France), 2 %
FBS and 1 % antibiotics (Invitrogen). At confluence,
differentiation into myotubes was induced by chan-
ging the medium to DMEM supplemented with 2 %
FBS. Four days after initiation of differentiation, cells
were polynucleated and expressed specific markers of
human skeletal muscle [41].
It has to be noticed that mycoplasma bacteria are
around 100 nm in size and can present a potential prob-
lem for accurate exosome measurements [42]. Thus, the
cells used in this study were tested and found to be
negative for mycoplasma.
mRNA quantitative real-time PCR
Total RNA was extracted from muscle cells by using
TriReagent® (Sigma) and quantify with NanoDrop 2000c
UV-Vis Spectrophotometer (Thermo Fisher Scientific).
RT-PCR was performed using ABsolute QPCR SYBR
Green ROX Mix (Abgene, Courtaboeuf, France) with a
Rotor-Gene 6000 system (Corbett Life Science, France).
Results were normalized either with the gene encoding
TBP (TATAbox binding protein) used as the reference
for the quantification of gene expression in myotubes
[43], or with the gene encoding CSNK2A2 (Casein
Kinase 2, Alpha Prime Polypeptide), when gene expres-
sion was quantified in myoblast [44].
PCR primers were CCND1 (cyclin D1) S-CTTCCTCT
CCAAAATGCCAG, and AS-TGGAGGGTGGGTTGG
AAATG, MYOG (myogenin) S-CAACCCAGGAGATC
ATTTGC and AS-CATATCCTCCACCGTGATGC, TBP
S-TTCACATCACAGCTCCCCAC and AS-TGGTGTG
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CACAGGAGCCAAG, IL-6 (interleukin-6) S-AGTTG
CCTTCTTGGGACTGAT and AS-TCCACGATTTCCC
AGAGAAC, CKMT2 (Creatine kinase S-type, mitochon-
drial) S-CTCATCGATGACCACTTTCTG and AS-ATT
CCACATGAACTCCCAGC, MYOD1 (myogenic differ-
entiation 1) S-TCCAGCCCGCGCTCCAACTGC and A
S-TCGACACGGCCGCACTCTTCC, GLUT4 (SLC2A4)
S-GGGTTTCCAGTATGTTGCGG and AS-CTGGGTT
TCACCTCCTGCTC, Sirt1 (Sirtuin 1) S-TGAGAAAA
TGCTGGCCTAATA and AS-GATAAGACGTCATCTT
CAGAG, Myostatin S-TGCTGTAACCTTCCCAGGA




PGC1 alpha S-TCCTCTGACCCCAGAGTCAC and
AS-CTTGGTTGGCTTTATGAGGAGG.
Of note, L6 myotubes do not express myostatin; primers
for MyoD amplification are not working for L6 RNA, and
Glut4 primers are not working for human RNA.
Western blotting
EV proteins were denatured in Laemmli Buffer (Tris-HCl
50 mM, Glycerol 12 %, SDS 1 %, beta-mercaptoethanol
4 %, Bromophenol blue 0.01 %, PH 6.8, (Sigma)) for 10 min
at 100 °C and were migrated on 10 % SDS-PAGE gels
(100 μg) and further transferred onto nitrocellulose
PVDF membranes. As a positive control, we used
muscle-released EVs from C2C12, previously well
characterized by our group [25, 38]. Membranes were
incubated with anti-Rabbit CD81, CD63, TSG101 [25].
Signals were revealed with Immuno detection kit ECL
Luminata Classico (Millipore) and the imager Molecu-
lar Image® ChemiDoc™XRS+ (Bio-Rad). Proteins quan-
tification was achieved using ImageLab 3.0 (Bio-Rad).
Transmission electron microscopy (TEM)
EVs in PBS were adsorbed on 200 Mesh nickel grids
coated with formar-C. Immunogold labelling was
performed by flotation of grids on drops of reactive
media. Non-specific sites were coated with 1 % BSA in
50 mM Tris–HCL, pH 7.4 for 10 min at RT. Antibody
incubation was carried out for 4 h at 4 °C in a wet
chamber with mouse monoclonal antibody raised against
CD81 (sc-31234) antibodies (Santa Cruz Biotechnology)
(dilution 1/50) in 1%BSA, 50 mM Tris–HCL, pH 7.4.
Grids were successively washed in 50 mM Tris–HCL,
pH 7.4 and pH 8.2 at RT. They were then preincubated
with 1 % BSA in 50 mM Tris–HCL, pH 8.2 for 10 min
at RT and labelled with a goat anti mouse IgG gold-
conjugated 10 nm, (Tebu bio, France) diluted 1/80 in
1 % BSA-, 50 mM Tris–HCL, pH 8.2 in a wet chamber
for 45 min. Grids were successively washed once in
50 mM Tris–HCL, pH 8.2 then pH 7.4 and in filtrated
distilled water at RT. Grids with suspensions were
colored with 2 % phosphotunstic acid for 2 min and
examined using a JEM Jeol 1400 transmission electron
microscope (Tokyo, Japan) equipped with a Orius 600
camera (USA).
Statistical analysis
All results were expressed in mean +/- standard error of
the mean (SEM). A parametric Student t-test was used
for mean comparison. A p value < 0.05 was considered
as significant.
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